D-0470-2017 Class III Terminated

Recalled by Aurobindo Pharma USA Inc — Plainsboro, NJ

FDA drug recall D-0470-2017 was initiated by Aurobindo Pharma USA Inc on Dec 16, 2016 and is designated Class III. Reason for recall: Discoloration: Some vials were found to contain powder with a yellowish-brownish appearance. The recall status is terminated (terminated Jul 29, 2020). Affected quantity: 29800 vials.

Recall details

Product Type
Drugs
Report Date
Feb 15, 2017
Initiation Date
Dec 16, 2016
Termination Date
Jul 29, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
29800 vials

Product description

Pantoprazole Sodium for Injection, 40mg per vial, Single-dose vial, Rx only, Mfd. in India for: Auromedics Pharma LLC 6 Wheeling Road, Dayton, NJ 08810, NDC 55150-202-00

Reason for recall

Discoloration: Some vials were found to contain powder with a yellowish-brownish appearance.

Distribution pattern

Nationwide in US

Code information

Lot #: CPO160028, Exp. June 2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0470-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0470-2017. Report a data issue: hello@regdatalab.com.